Home > Inhibitors & Agonists > Antibiotics and Antivirals > HBV
Cat. No. Product name CAS No.
DC10797 AB423

AB-423 is the first-generation Hepatitis B Virus Capsid Assembly inhibitor, which was generally safe and well tolerated in Phase 1 healthy volunteer studies.

1572510-80-5
DC10294 Bay 41-4109

BAY 41-4109 is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM.

298708-81-3
DC10085 Bay 41-4109 (racemate)

BAY 41-4109 racemate is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM.

298708-79-9
DC11296 GLP-26

GLP-26 is a novel potent HBV capsid modulator that reduces secreted HBeAg in HepNTCPDL cells transfected with HBV wild type with EC50 of 0.7 uM.

2133017-36-2
DC10882 JNJ-632

JNJ-632 is a novel and potent inhibitor of HBV replication in vitro across genotypes A-D.

1572510-42-9
DC11260 NTCP binder peptide WD1

NTCP binder peptide WD1 is a macrocyclic peptide, pan-genotypic inhibitor of HBV cellular entry via targeting the cell-surface receptor for HBV, sodium taurocholate cotransporting polypeptide (NTCP, Kd=15 nM), reduces HBs antigen levels in culture supernatants.

DC11259 NTCP binder peptide WL4

NTCP binder peptide WL4 is a macrocyclic peptide, pan-genotypic inhibitor of HBV cellular entry via targeting the cell-surface receptor for HBV, sodium taurocholate cotransporting polypeptide (NTCP, Kd=42 nM), reduces HBs antigen levels in culture supernatants with IC50 of 0.66 uM.

Page 1 / Total 1 FirstPrevNextLastGoto